Fundz

Jnana Therapeutics Appoints George Vratsanos, M.D., as

PRIVATEJul 19, 2023

Position

Chief Medical Officer

Company

Jnana Therapeutics Inc.

George Vratsanos
gvratsanos@jnanatx.com
BostonBiotechnologyHealth CareTransportation

Description

BOSTON, July 19, 2023 -- Jnana Therapeutics , a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced the appointment of George Vratsanos, M.D., F.A.C.R., to chief medical officer and head of research and development. Dr. Vratsanos brings over 20 years of experience in roles spanning translational medicine, late-stage therapeutics development, and medical affairs

Who to call at Jnana Therapeutics Inc., and when

A new leader at Jnana Therapeutics Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Jnana Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jnana Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Jnana Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jnana Therapeutics Inc.

Location

6 Tide Street

Boston, Massachusetts, United States

About

Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemoproteomics RAPID platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet need. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases, immune-mediated diseases and cancer. Jnana’s wholly owned lead program is a potential first-in-class oral approach, targeting an allosteric site on the phenylalanine transporter SLC6A19, for the treatment of phenylketonuria (PKU), a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, a highly experienced management team and the backing of leading life science investors Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures and AbbVie Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jnana Therapeutics Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

George
Likely contact at this company
••••••••@••••••••

See George's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Jnana Therapeutics Inc.'s next move

Learn about Strategic plan

Jnana Therapeutics Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.